Navigation Links
Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting
Date:6/12/2008

DENVER, June 12 /PRNewswire/ -- Cancer Clinics of Excellence (CCE), the nation's only practice-owned and physician driven network of community oncologists has announced its management slate and Board of Directors. Effective immediately, J. Ike Nicoll is President/COO of CCE. Most recently, he was the interim President of CCE. In addition, Linda Bosserman, MD, Wilshire Oncology Medical Group was named Chief Medical Officer. Dr. Bosserman had previously served as CCE's Chief Quality Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080612/AQTH094LOGO)

"Ike brings management breadth to CCE with his expertise in a wide variety of healthcare issues including administrative and claims management, drug discovery/FDA approval, clinical trials, supply chain management, payer/provider operations, provider contracting and revenue cycle management," stated CCE Chairman, Arthur "Chip" Staddon, MD. "Dr. Bosserman is a nationally renowned expert in the field of quality management, outcomes measurement and electronic medical record implementation. With Ike and Dr. Bosserman leading CCE in our business and clinical objectives, CCE is well placed to lead the most needed initiatives to improve oncology care in the United States," added Dr. Staddon.

The CCE Board of Directors is comprised of Arthur Staddon, MD, Pennsylvania Oncology; Frederick Schnell, MD, Central Georgia Cancer Care, Shahab Dadjou, CEO, Redwood Regional Medical Group; Paul Julian, EVP and Group President, McKesson Corporation and Patrick Blake, President, McKesson Specialty Care Solutions.

"The structure and breadth of the CCE Board of Directors represents the strength of our national network and the support of our strategic partner the McKesson Corporation," stated Arthur "Chip" Staddon, MD. "CCE provides our membership with a robust set of tools and resources, including our proprietary Evidence Based Treatment Protocols, to enhance our clinical efficiency and effectiveness."

These announcements were made at CCE's First Annual Membership meeting in New Orleans, LA. Over 100 clinicians attended the meeting which was created to fulfill the needs of both the clinicians and practice administrators. Clinical presentations by Frank Giles, MD, UT San Antonio; Funmi Olopade, MD, University of Chicago; Michael Fisch, MD, MD Anderson; Barbara Murphy, MD, Vanderbilt Ingram; Alan Sandler, MD, Vanderbilt Ingram; Ezekiel Emanuel, MD, National Institutes of Health; Bert O'Neil, MD, University of North Carolina; and Robert Vescio, MD, Cedars Sinai were complemented by practice management sessions on Malpractice Management, Compliance Pitfalls for Ancillary Services, New Revenue Generation and Integrating Orals into Your Practice.

About Cancer Clinics of Excellence

Cancer Clinics of Excellence is the only practice owned and physician driven network that empowers oncologists to deliver proven, evidence-based treatment in community settings while ensuring the performance of their practices. For more information, visit us at http://www.cce.us.com.


'/>"/>
SOURCE Cancer Clinics of Excellence
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Primary tumors can drive the growth of distant cancers
2. Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer
3. Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection
4. Primary Tumors Fuel Growth of Cancer Cells
5. American Idol Winner David Cook to Perform at and Jimmy Kimmel to Host Jonsson Cancer Center Foundations Taste for a Cure on June 21
6. DNA Coding May Make Bowel Prone to Cancer
7. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
8. Cancer was one of the best things to happen to me ... but I worry about the future
9. Raloxifene Cuts Risk of Certain Type of Breast Cancer
10. Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women
11. Cancer-killing viruses influence tumor blood-vessel growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
(Date:12/8/2016)... JENNERSVILLE, Pa. (PRWEB) , ... December 08, 2016 ... ... Penn Medicine Southern Chester County, a Property owned by an affiliate of Seavest, ... 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it had joined the Pharmaceutical ... a non-profit organization to unite pharmaceutical and healthcare companies that share a vision ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec 9, 2016 Research and Markets has announced ... Business Report" report to their offering. ... The report also analyses the market by the following ... comprehensive analytics for the US, Canada , ... , Latin America , and Rest of World. ...
(Date:12/9/2016)... Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... of Physiocrine-based therapeutics to address severe, rare diseases, today announced that ... BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel ... 14, 2016, at 4:20 p.m. ET. About aTyr ... aTyr ...
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
Breaking Medicine Technology: